fentanyl
Commercial- Indications
- Chronic pain, Cancer pain
Company intelligence / Profile preview
Sparsha Pharma
Oceanside, California, USAsparshausa.com ↗
- Ownership
- Private
- Employees
- ~55
- Development stage
- Commercial
01
Overview
Successfully launched lidocaine 4% over-the-counter patch (Niravi) in 2020 and produces private-label lidocaine 4% patches for several customers including major pharmacies
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Transdermal patchesTopical patchesOral filmsSublingual films
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
Japanese partners (unspecified)Nissha Co., Ltd.major pharmacies for private-label products
Beyond the preview
Go deeper on Sparsha Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sparsha Pharma.